Maria Foggia
Overview
Explore the profile of Maria Foggia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pietroluongo E, Peddio A, De Placido P, Tortora M, Ottaviano M, Gelzo M, et al.
BMC Cancer
. 2024 Jun;
24(1):748.
PMID: 38898390
Introduction: Thymic epithelial tumors (TETs) are rare neoplasms often associated with immune-related disorders. Patients with Good's syndrome (GS), an adult-acquired TET-related immunodeficiency, are at a high risk of mortality due...
2.
Gentile I, Foggia M, Silvitelli M, Sardanelli A, Cattaneo L, Viceconte G
Virol J
. 2023 Dec;
20(1):301.
PMID: 38102675
Background: Morbidity and mortality are higher in immunocompromised patients affected by COVID-19 than in the general population. Some authors have successfully used antiviral combination, but never in the early phase...
3.
Piemonti L, Landoni G, Voza A, Puoti M, Gentile I, Coppola N, et al.
Infect Dis Ther
. 2023 Oct;
12(10):2437-2456.
PMID: 37798468
Introduction: Polymorphonuclear cell influx into the interstitial and bronchoalveolar spaces is a cardinal feature of severe coronavirus disease 2019 (COVID-19), principally mediated by interleukin-8 (IL-8). We sought to determine whether...
4.
Viceconte G, Buonomo A, DAgostino A, Foggia M, Di Fusco A, Pinchera B, et al.
J Fungi (Basel)
. 2023 Aug;
9(8).
PMID: 37623609
Background: Very few cases of pneumonia (PJP) have been reported in COVID-19 so far, and mostly in patients with concomitant HIV infection or in solid-organ transplant recipients. Despite COVID-19 being...
5.
Scotto R, Buonomo A, Iuliano A, Foggia M, Sardanelli A, Villari R, et al.
Vaccines (Basel)
. 2023 Feb;
11(2).
PMID: 36851078
Early treatment with antivirals against SARS-CoV-2 infection can prevent the onset of severe COVID-19 in fragile and immunocompromised patients. In this real-life, prospective, observational study, we evaluated efficacy and safety...
6.
Schiano Moriello N, Buonomo A, Scotto R, Pinchera B, Sarno M, Fusco L, et al.
Heliyon
. 2023 Jan;
9(2):e13126.
PMID: 36713627
Since 2020, COVID-19 pandemic has spread worldwide causing a huge number of cases and casualties. Among direct anti SARS-CoV-2 agents available for the treatment of COVID-19, only remdesivir and casirivimab/imdevimab...
7.
Scotto R, Lanzardo A, Buonomo A, Pinchera B, Cattaneo L, Sardanelli A, et al.
Vaccines (Basel)
. 2022 Dec;
10(12).
PMID: 36560453
We evaluated the role of CRP and other laboratory parameters in predicting the worsening of clinical conditions during hospitalization, ICU admission, and fatal outcome among patients with COVID-19. Consecutive adult...
8.
Viceconte G, Ponsiglione A, Buonomo A, Camera L, Scotto R, De Giorgi M, et al.
Infez Med
. 2022 Dec;
30(4):555-562.
PMID: 36482955
Purpose: To assess clinical, laboratory and radiological differences between Delta and Alpha SARS-CoV-2 variants. Materials And Methods: Twenty SARS-CoV-2 patients admitted from 30th of August to 30th of October 2021...
9.
Pinchera B, Spirito L, Buonomo A, Foggia M, Carrano R, Salemi F, et al.
Front Med (Lausanne)
. 2022 Jul;
9:852973.
PMID: 35801204
Introduction: In solid organ transplant recipients, COVID-19 is associated with a poor prognosis because of immunosuppression. Some studies suggest a potential therapeutic role of mammalian Target of Rapamycin (mTOR) inhibitors...
10.
Buonomo A, Viceconte G, Pinchera B, Scotto R, Zappulo E, Foggia M, et al.
Rev Recent Clin Trials
. 2022 May;
PMID: 35546746
No abstract available.